๐Ÿ”ฌDeep Research

MGRX โ€” Mangoceuticals Inc ยท catalysts, narrative & risks

ยท17 sourcesMGRX forecast โ†’

Snapshot (as of Nov 9โ€“10, 2026)

Mangoceuticals, Inc. (NASDAQ: MGRX) is a microcap men's (and women's) wellness telemedicine company headquartered in Dallas, Texas, founded in 2021 and described as an affiliate of Cohen Enterprises, Inc. [10][15][17]. On its last trading print, the stock closed at ~$0.197 (+3.63%) on November 9, with a market capitalization of roughly $4.38 million, a 52-week range of ~$0.16โ€“$2.41, and a beta of 2.15 [7][10][13][14]. Over the trailing year the shares fell approximately 91%, and were down about 73% year-to-date versus an S&P 500 gain, underscoring the asset's extreme volatility and underperformance [7][13][14]. It trades on the Nasdaq Capital Market [17].


AI-assisted research from the K3vl4r desk โ€” not personalized investment advice. More research โ†’